Deep Medicine Acquisition - Tradeable Rights - Oct 2026 OverviewDeep Medicine Acquisition - Tradeable Rights - Oct 2026 EBIT
EBIT (Earnings Before Interest and Taxes) analysis for DMAQR.
Quarterly EBIT
-$1.29M
↓ 9.74% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$12.15M
↓ 471.83% YoY
Trailing 12 months ending Mar 31, 2026